The Best Management for Most Patients with Incurable Cancer is on a Clinical Trial

Ann Oncol. 2024 Nov 14:S0923-7534(24)04913-5. doi: 10.1016/j.annonc.2024.11.007. Online ahead of print.

Authors

V Subbiah¹, R Kurzrock²

Affiliations

¹ Sarah Cannon Research Institute, Nashville, TN, United States. Electronic address: https://twitter.com/VivekSubbiah.
² Genomic Sciences and Precision Medicine Center, and Medical College of Wisconsin Cancer Center Milwaukee Wisconsin, USA; WIN Consortium, Paris, France; University of Nebraska.

PMID: 39550034
DOI: 10.1016/j.annonc.2024.11.007

No abstract available

Publication types

Editorial